Dr. Marta Rodriguez-Aller is a researcher whose interest is centered on the formulation and delivery of challenging actives; such as insoluble, unstable or structurally-complex drugs. She is passionate by creating new strategies based on pharmaceutical technology (e.g. prodrug design, drug complexation with cyclodextrins or drug combination with biodegradable polymers). She obtained her pharmacy degree from the University Complutense of Madrid (Spain) before joining the University Claude Bernard, Lyon I (France) where she graduated as the valedictorian and was awarded with an excellence grant. She then joined the University of Geneva (Switzerland) to perform her PhD in collaboration with clinical and research institutions from Europe and North America. After her PhD, she worked with formulations containing monoclonal antibodies (mAbs) and antibody-drug-conjugates (ADCs) in collaboration with Pierre Fabre Laboratories (France). She was also invited to give presentations at international conferences. She was also invited by the Dean of the faculty of Sciences of the University of Geneva to present her work at the graduation ceremony opening.
She recently joined GlaxoSmithKline as Research and Development Senior Scientist where she is expanding her knowledge and experience on the pharmaceutical industrial environment.